HD-OPM Archive
Topics › Insulin resistance & diabetes

Reprogrammed stem-cell islet transplant freed a woman with type 1 diabetes from insulin

Louis Nervegna · Sep 28, 2024 · ♥ 10 reactions · 6 comments · original Facebook post
Insulin resistance & diabetes
AI summary & key facts

Shared from Luigi Fontana: a 25-year-old woman with type 1 diabetes received autologous chemically induced pluripotent stem cell islets under the abdominal rectus sheath. She stopped needing insulin within 2.5 months, with time-in-range rising from 43.18% to 96.21% by month 4 and above 98% afterward (HbA1c about 5%). At 1 year all endpoints were met with no transplant-related issues. A single patient, and about type 1 not cardiovascular disease.

(no text — see the shared post below)

Research cited

A breakthrough in type 1 diabetes treatment: A 25-year-old woman with type 1 diabetes is now producing her own insulin following a autologous transplant of reprogrammed stem cells (CiPSC islets) beneath the abdominal anterior rectus sheath. Conducted by Deng Hongkui’s team at Peking University, this pioneering procedure eliminated her need for insulin within 2.5 months, with glycemic control improving from 43.18% to 96.21% time-in-target range by month 4, and stable control thereafter (>98% time-in-range, ~5% glycated hemoglobin). At 1 year, all study endpoints were met with no transplant-related issues. These promising results support further clinical trials of CiPSC-islet transplantation for type 1 diabetes. These advancements could revolutionize type 1 diabetes care, offering hope to millions worldwide.

DOI: 10.1016/j.cell.2024.09.004

#DiabetesResearch #StemCells #HealthcareInnovation

No photo description available.No photo description available.
← newer: Short video summarizing the evidence that cholesterol is cauolder: Louis attributes the obesity crisis to rising daily calorie →